Thromboprophylaxis for Patients in ICU With COVID-19
Effectiveness of Thromboprophylaxis With Low Molecular Weight Heparin in Critically Ill Patients With COVID-19. A Prospective, Cohort, Multicenter Study.
Sponsor: Hospital Clinic of Barcelona
This observational or N/A phase trial investigates Anticoagulant Therapy and Covid19 and is currently completed. Hospital Clinic of Barcelona leads this study, which shows 6 recorded versions since 2020 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
6 versions recorded-
Apr 2025 — Present [monthly]
Completed
-
Sep 2024 — Apr 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Apr 2022 — Jul 2024 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Jan 2021 — Apr 2022 [monthly]
Active Not Recruiting
▶ Show 1 earlier version
-
Dec 2020 — Jan 2021 [monthly]
Active Not Recruiting
First recorded
Mar 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Hospital Clinic of Barcelona
- Hospital Universitario Doctor Peset
- Hospital Universitario La Fe
- Hospital Universitario La Paz
- Hospital de Cruces
- Hospital de Sant Joan Despí Moisès Broggi
- Instituto de Investigacion Sanitaria La Fe
- University of Navarrra Hospital (Clinica Universitaria)
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
A Coruña, Spain , Alicante, Spain , Barcelona, Spain , Ciudad Real, Spain , Cáceres, Spain , Las Palmas, Spain , Leganés, Spain , León, Spain , Madrid, Spain , Murcia, Spain and 6 more locations